|
|||||
|
|
Her2 positive breast cancer: practices |
|
| Authors: | Campone Mario Berton-Rigaud Dominique Bourbouloux Emmanuelle Sophie Sadot Zanetti Alain Frenel Jean-Sébastien |
| Affiliation: | Institut du cancer Nantes-Atlantiques, centre René-Gauducheau, Saint-Herblain, France. m-campone@nantes.fnclcc.fr |
| Abstract: | The molecular classification of Perou and Sørlie breast tumors has to streamline, systematize and make effective use of targeted therapies against specific molecular subtypes, including breast HER2 positive. Trastuzumab and lapatinib are currently the two therapies targeting HER2, which have demonstrated their effectiveness in clinical practice. This literature review aims to make the data points on pertinent and useful data for physicians in daily |
| Keywords: | cancer du sein thérapie anti-HER2 lapatinib trastuzumab revue Her2 breast cancer trastuzumab lapatinib |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |